Moreover, MLT was proved, by Rahimi et al., 2017, to be a promising adjuvant of DNA vaccines against human papillomavirus (HPV)-associated cancers that significantly induced strong HPV16 E7-specific CD8+ cytotoxicity and IFN-γ response [28]. The gene discussed is CD8A; the disease is cancer.